JPMORGAN CHASE & CO - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 24 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,880
-99.6%
3,000
-99.6%
0.00%
Q1 2023$778,000
+92189.4%
777,0000.0%0.00%
Q4 2022$843
-99.9%
777,000
-12.3%
0.00%
Q3 2022$889,000
+272.0%
886,000
+290.3%
0.00%
Q2 2022$239,000
-8.1%
227,0000.0%0.00%
Q1 2022$260,000
+29.4%
227,000
+24.0%
0.00%
Q4 2021$201,000
+31.4%
183,000
+41.9%
0.00%
Q2 2021$153,000
-95.2%
129,000
-95.4%
0.00%
Q4 2020$3,165,000
+119.0%
2,829,000
+98.5%
0.00%
Q3 2020$1,445,0001,425,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Wellesley Asset Management 12,388$12,458,0000.88%
SHENKMAN CAPITAL MANAGEMENT INC 13,818,000$13,900,0000.78%
ABSOLUTE INVESTMENT ADVISERS, LLC 3,500,000$3,510,0000.62%
WOLVERINE ASSET MANAGEMENT LLC 28,655,000$28,803,0000.31%
TENOR CAPITAL MANAGEMENT Co., L.P. 12,334,000$12,434,0000.28%
CSS LLC/IL 5,000,000$5,024,0000.24%
CAPSTONE INVESTMENT ADVISORS, LLC 22,700,000$22,913,0000.14%
Jefferies Group LLC 7,347,000$7,413,7240.06%
FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. 26,000$26,0000.04%
Calamos Advisors LLC 7,500,000$7,542,0000.03%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders